Vinge advises Wilson Therapeutics in connection with directed share issue

Vinge has advised Wilson Therapeutics on a directed new issue of shares, whereby Wilson Therapeutics raises proceeds of approximately SEK 244 million, before issue costs.

Vinge advises Tempest Security in connection with listing on Nasdaq First North

Vinge has advised Tempest Security AB (publ) in connection with its listing on Nasdaq First North. The first day of trading was 6 December 2017.

Vinge advises Lyko Group in connection with its listing on Nasdaq First North Premier

Vinge has advised Lyko Group AB (publ) (“Lyko”) in connection with its listing on Nasdaq First North Premier.

Vinge advised Lifco on bond issue

Lifco AB (publ) has issued two unsecured bond loans of in total SEK 1,000 million, with a tenor of two years.

Vinge assists Adven in connection with its acquisition of a district heating company from E.ON

Vinge advises Adven Sweden AB in connection with its acquisition of E.ON Värme Lokala Energilösningar Aktiebolag.

Vinge advised Ernström & C:o

Vinge has advised Ernström & C:o in conjunction with the investment and acquisition of shares in CellMark Investment.

Vinge advises Erik Hemberg Fastighets AB on its mandatory offer for Götenehus

Vinge advises Erik Hemberg Fastighets AB on its mandatory offer for Götenehus

Atria sells Nordic Fast Food to FIAB

Vinge has advised Atria in conjunction with the sale of its holding in Nordic Fast Food AB to the previous minority shareholder Svenska Franchisetagarnas Intresse AB (FIAB).

Vinge advises Hansa Medical in connection with directed share issue

The board of directors of Hansa Medical has resolved on a directed new issue of ordinary shares, subject to approval by an extraordinary general meeting, whereby Hansa Medical will raise proceeds of approximately SEK 545 million, before issue costs.

Vinge advises Industrifonden in connection with investment in DPOrganizer

Vinge has advised Industrifonden in connection with a EUR 3 million financing round in DPOrganizer.

IK VII Fund divests Ramudden Group

Vinge has advised IK VII Fund and other owners in connection with the sale of the Ramudden group to Triton.

Vinge advises Sigrid Therapeuctis AB on share issues

Vinge has advised Sigrid Therapeuctis AB in connection with a combined directed issue and rights offering.

Vinge advises IBT on share issues

Vinge advises Infant Bacterial Therapeutics AB (publ) (Nasdaq First North Premier) in connection with a combined directed issue and rights offering of approximately SEK 545 million.

WallVision acquires Wall&decó

Vinge together with the Italian law firm Pavia e Ansaldo have advised WallVision in conjunction with the acquisition of the Italian premium brand Wall&decó.

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group

Vinge acts as counsel to Orkla in connection with the acquisition of Health and Sports Nutrition Group HSNG AB (”HSNG”). The seller is Qliro Group AB (publ).